Information about GlobalPharmacyMeds.to
List of countries where we can ship Dolutegravir:
Latest news releases on Dolutegravir:
Learn more about TIVICAY (dolutegravir) for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in treatment-naïve and treatment-experienced patients.
Dolutegravir Sodium reference guide for safe and effective use from the American Society of Health-System Pharmacists (AHFS DI).
A Project of the International Association of Providers of AIDS Care. Fact Sheets can be downloaded from the Internet at http://www.aidsinfonet.org
HTB. Dolutegravir monotherapy studies halted due to integrase resistance: dual therapy studies continue. 27 February 2017. Related: Conference reports, Treatment ...
The aim of this study is to determine if virologically suppressed, human immunodeficiency virus type 1 (HIV-1) infected adults on an antiretroviral regimen (including ...
Two studies presented at the same session looked at dolutegravir monotherapy as a maintenance option for people with viral suppression on other regimens.
The latest worldwide HIV/AIDS news and updates, including treatment, prevention, and hepatitis and TB co-infections.
A collection of patient education fact sheets on HIV/AIDS treatments and conditions, in English and Spanish. Also, an extensive listing of AIDS-related internet web ...
Dolutegravir (DTG) is a potent INSTI with high genetic barrier. The once-daily (QD) DTG-3TC combination is attractive, both drugs being safe, highly efficient and ...
FULL PRESCRIBING INFORMATION 1 INDICATIONS AND USAGE . TIVICAY ® is indicated in combination with other antiretroviral agents for the treatment